Current status: 937 hESC lines, 4397 hiPSC lines, and 125 clinical studies, and 1121 certificates
Monthly statistic from Sep 1, 2023
Posted on September 1, 2023
| total lines | 5334 |
| hESC lines | 937 |
| hiPSC lines | 4397 |
| derivation countries | 46 |
| projects | 277 |
| providers | 837 |
| clinical studies | 125 |
| subclones | 2273 |
| certificates | 1121 |
| cell line certificates | 981 |
| project certificates | 140 |